Cellectar Biosciences, Inc. Public Float
Cellectar Biosciences, Inc. (CLRB) had Public Float of $12.85 million as of 2025-06-30, per its 10-K/A filed 2026-04-30.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-04-30
- 2025-06-30: Entity Public Float $12.85M.
- 2024-06-28: Entity Public Float $89.10M.
- 2023-06-30: Entity Public Float $18.92M.
- 2022-06-30: Entity Public Float $24.32M.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $12.85M 10-K/A · filed 2026-04-30 |
| 2024-06-28 | $89.10M 10-K · filed 2025-03-13 |
| 2023-06-30 | $18.92M 10-K/A · filed 2024-10-29 |
| 2022-06-30 | $24.32M 10-K/A · filed 2023-03-16 |
| 2021-06-30 | $65.45M 10-K · filed 2022-03-21 |
| 2020-06-30 | $32.35M 10-K · filed 2021-03-02 |
| 2019-06-30 | $20.26M 10-K · filed 2020-03-09 |
| 2018-06-30 | $10.37M 10-K · filed 2019-02-26 |
| 2017-06-30 | $20.82M 10-K · filed 2018-03-21 |
| 2016-06-30 | $15.55M 10-K · filed 2017-03-15 |
| 2015-06-30 | $12.89M 10-K/A · filed 2016-10-20 |
| 2014-06-30 | $12.79M 10-K · filed 2015-05-20 |
| 2013-06-30 | $20.80M 10-K · filed 2014-03-19 |
| 2012-06-30 | $38.21M 10-K · filed 2013-03-28 |
| 2011-06-30 | $22.70M 10-K · filed 2012-03-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |